{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:49:17Z","timestamp":1776469757966,"version":"3.51.2"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.annemergmed.2012.12.017","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T13:43:04Z","timestamp":1364305384000},"page":"244-251","source":"Crossref","is-referenced-by-count":37,"title":["A 9-State Analysis of Designer Stimulant, \u201cBath Salt,\u201d Hospital Visits Reported to Poison Control Centers"],"prefix":"10.1016","volume":"62","author":[{"given":"Brandon J.","family":"Warrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Hekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel J.","family":"Casavant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Mowry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Spiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Aleguas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gummin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Nezlek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Smolinske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2012.12.017_bib1","first-page":"574","article-title":"Comprehensive drug analysis of \u201cbath salts\u201d purchased in the United States","volume":"50","author":"Schneir","year":"2012","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib2","series-title":"The Shulgin Index Vol. I: Psychedelic Phenethylamines and Related Compounds","year":"2011"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib3","first-page":"74","article-title":"Structure-activity relationships of the classic hallucinogens and their analogs [review]","volume":"146","author":"Jacob","year":"1994","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib6","first-page":"624","article-title":"Emergency department visits after use of a drug sold as \u201cbath salts\u201d\u2014Michigan, November 13, 2010\u2013March 31, 2011","volume":"60","author":"Benzie","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/00952990.2012.677890","article-title":"Synthetic cathinone exposures reported to Texas poison centers","volume":"38","author":"Forrester","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/15563650.2011.635149","article-title":"2010 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th annual report","volume":"49","author":"Bronstein","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13181-011-0199-6","article-title":"Lethal serotonin syndrome after methylone and butylone ingestion","volume":"8","author":"Warrick","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/emj.2010.096636","article-title":"Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service","volume":"28","author":"James","year":"2011","journal-title":"Emerg Med J"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/emj.2010.103093","article-title":"Mephedrone toxicity in a Scottish emergency department [review]","volume":"28","author":"Regan","year":"2011","journal-title":"Emerg Med J"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","article-title":"Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines","volume":"381","author":"Cozzi","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib14","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.annemergmed.2012.12.017_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF03160901","article-title":"Foxy methoxy: a new drug of abuse","volume":"1","author":"Smolinske","year":"2005","journal-title":"J Med Toxicol"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064412018495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064412018495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T18:55:23Z","timestamp":1539802523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064412018495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0196064412018495"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2012.12.017","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}